AHA 2021: AXIOMATIC-TKR Demonstrates Promise for Oral Milvexian in Prevention of Venous Thromboembolism After Total Knee Replacement
The investigational drug compared well with enoxaparin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.